0001753926-24-000573.txt : 20240319 0001753926-24-000573.hdr.sgml : 20240319 20240319182108 ACCESSION NUMBER: 0001753926-24-000573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaufman Jonathan H CENTRAL INDEX KEY: 0001959250 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41575 FILM NUMBER: 24765485 MAIL ADDRESS: STREET 1: C/O LIPELLA PHARMACEUTICALS INC. STREET 2: 7800 SUSQUEHANNA ST., SUITE 505 CITY: PITTSBURGH STATE: PA ZIP: 15208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIPELLA PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001347242 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 N LEXINGTON ST STREET 2: STE LL103 CITY: PITTSBURGH STATE: PA ZIP: 15208 BUSINESS PHONE: 412-901-0315 MAIL ADDRESS: STREET 1: 400 N LEXINGTON ST STREET 2: STE LL103 CITY: PITTSBURGH STATE: PA ZIP: 15208 FORMER COMPANY: FORMER CONFORMED NAME: LIPELLA PHARMACEUTICALS INC DATE OF NAME CHANGE: 20051219 4 1 ownership.xml FORM 4 X0508 4 2024-03-15 0 0001347242 LIPELLA PHARMACEUTICALS INC. LIPO 0001959250 Kaufman Jonathan H C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208 1 1 1 0 See remarks below. 0 Common Stock 2024-03-18 4 P 0 30000 0.7883 A 863849 D Common Stock 2024-03-19 4 P 0 25000 0.8721 A 888849 D Stock Options 0.77 2024-03-15 4 A 0 80000 0 A 2024-03-15 2034-03-15 Common Stock 80000 80000 D Open market purchase by the reporting person of 30,000 shares of common stock, par value $0.0001 per share (the "Common Stock"). Reflects the weighted average price of the shares purchased on the open market in multiple transactions on March 18, 2024 at prices ranging from $0.77 to $0.80 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range. Open market purchase by the reporting person of 25,000 shares of Common Stock. Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on March 19, 2024 at prices ranging from $0.75 to $0.89 per share, inclusive. President, Chief Executive Officer, Secretary, Treasurer, and Chairman of the Board of Directors /s/ Jonathan H. Kaufman 2024-03-19